Signal active
Organization
Contact Information
Overview
We believe that with the current technology society is on the verge of creating a bio-based economy. EV Biotech will evolve the chemical feedstock market by revolutionizing the methods of microbial cell factory strain engineering; hereby shifting the chemical market from petrochemical-based to biological-based chemical production. A revolutionary step for a more sustainable world.
About
Biotechnology, Food and Beverage, Cosmetics, Nutrition, Personal Care and Hygiene
2018
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
EV Biotech headquartered in Europe, operates in the Biotechnology, Food and Beverage, Cosmetics, Nutrition, Personal Care and Hygiene sector. The company focuses on Biotechnology and has secured $369.8M in funding across 60 round(s). With a team of 11-50 employees, EV Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - EV Biotech, raised $4.9M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
13
0
$6.2M
Details
2
EV Biotech has raised a total of $6.2M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed | 1.3M | ||
2023 | Seed | 4.9M |
Investors
EV Biotech is funded by 16 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Marc Kaptein | - | FUNDING ROUND - Marc Kaptein | 4.9M |
Scott Saxberg | - | FUNDING ROUND - Scott Saxberg | 4.9M |
EV Biotech | - | FUNDING ROUND - EV Biotech | 4.9M |
Hannu Ryopponen | - | FUNDING ROUND - Hannu Ryopponen | 4.9M |
Recent Activity
There is no recent news or activity for this profile.